Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats

Journal of Hypertension

Volumn 15, Issue 9, 1997, Pages 945-954

  Black, M Jane ^a,b   Kanellakis, Peter ^a   Bobik, Alex ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme inhibition; Angiotensin II; Angiotensin type 1 antagonism; Blood vessels; Heart; Hypertension; Losartan; Prehypertensive hypertrophy; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART DEVELOPMENT; HEART LEFT VENTRICLE; HEART WEIGHT; HYPERTENSION; HYPERTROPHY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY MASS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION;

EID: 0030754449     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715090-00004     Document Type: Article

References (30)

1. Lee RMKW: Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats. Blood Vessels 1985, 22:105-126.
2. Eccleston-Joyner LA, Gray SD: Arterial hypertrophy in the fetal and neonatal spontaneously hypertensive rat. Hypertension 1988, 12:513-518.
3. Adams MA, Bobik A, Korner PI: Differential development of vascular and cardiac hypertrophy in genetic hypertension (relationship to sympathetic function). Hypertension 1989, 14:191-202.
4. Adams MA, Bobik A, Korner PI: Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 1990. 15:252-260.
5. Oddie CJ, Dilley RJ, Bobik A: Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers. Clin Exp Pharmacol Physiol 1992, 19:392-395.
6. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Koorsgaard N et al.: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991, 17:626-635.
7. Black MJ, Bertram JF, Campbell JH, Campbell GR: Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. J Hypertens 1995. 13:683-692.
8. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, et al.: Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibitor or angiotensin II antagonism. Kidney Int 1994, 45:485-492.
9. Luke RG: Essential hypertension: a renal disease? A review and update of the evidence. Hypertension 1993, 21:380-390.
10. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R. Triggle CR: Prevention of hypertension and vascular changes by captopril treatment Hypertension 1991, 17:141-150.
11. Gohlke P, Lamberty V, Kuwer I, Bartebach S, Schnell A, Unger T: Vascular remodelling in systemic hypertension. Am J Cardiol 1993, 71:2E-7E.
12. Wu J-N, Edwards DG, Zhang L, Berecek KH: Effects of early treatment of spontaneously hypertensive rats with an angiotensin converting enzyme inhibitor on blood pressure baroflex function and cardiac hypertrophy. Hypertens Res 1994, 17:243-251.
13. Speller AM, Moffat OB: Tubulo-vascular relationships in the developing kidney. J Anat 1977. 123:487-500.
14. Folkow B, Grimby G, Thulesius O: Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 1958, 44:255-272.
15. Korner PI, Angus JA: Structural determinants of vascular resistance properties in hypertension. Haemodynamic and model analysis. J Vasc Res 1992, 29:293-312.
16. Bobik A, Dilley R. Kanellakis P: Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine. J Hypertens 1997, in press.
17. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH: Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990, 15:44-55.
18. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990, 259:H610-H618.
19. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984.
20. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990, 16:603-614.
21. Gray SD: Anatomical and physiological aspects of cardiovascular function in Wistar-Kyoto and spontaneously hypertensive rats at birth. Clin Sci 1982, 63 (suppl 8):383s-385s.
22. Wu JN, Berecek KH: Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 1993, 22:139-146.
23. Myers MM, Handler-Matasar SR, Shair HN: Effects of neonatal growth on adult blood pressures of borderline hypertensive rats. Hypertension 1996, 27:96-101.
24. Oddie CJ, Dilley RJ, Kanellakis P. Bobik A: Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens 1993, 11:717-724.
25. Christensen HRL, Nielsen H, Christensen KL, Baandrup V, Jespersen LT, Mulvany MJ: Long-term effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure? J Hypertens 1988. 6 (suppl 3):S27-S31.
26. Mulvany MJ, Persson EG, Andresen J: No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991, 9:589-593.
27. Morton JJ, Beatie EC, Macpherson F: Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vase Res 1990, 29:264-269.
28. Harrap SB, Nicolaci JA, Doyle AE: Persistent effects on blood pressure and renal hemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 1986. 13:753-765.
29. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR: Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat. J Hypertens 1989, 7:997-1003.
30. Okunishi H, Kawamoto T, Kurobe Y, Oka Y, Ishii K, Tanaka T, et al.: Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat Clin Exp Pharmacol Physiol 1991, 18:649-659.